Clinical Trial Update: Study of the Effects of Iron on Lung Blood Pressure at High Altitude [Phase 2]

View source ↗

Summary

This Clinical Trial Update indicates that the Phase 2 study of the effects of iron on lung blood pressure at high altitude has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Iron (ferrous iron)

Snippet

Sponsor: University of Oxford | Conditions: Hypertension, Pulmonary | Phase 2 | Status: WITHDRAWN